These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Reverse transcriptase activity (RTA) in lymphocyte cultures of HIV-infected patients receiving short treatments of HPA 23. A biological evaluation. Vittecoq D; Woerle R; Barre-Sinoussi F; Chermann JC Biomed Pharmacother; 1988; 42(1):35-9. PubMed ID: 2457397 [TBL] [Abstract][Full Text] [Related]
5. Therapeutic trials with HPA23, alpha-IFN and ribavirin in AIDS patients. Moroni M; Lazzarin A; Orlando G; Crocchiolo P; Castagna A; Verani P Chemioterapia; 1987 Jun; 6(2 Suppl):639-41. PubMed ID: 3509513 [No Abstract] [Full Text] [Related]
6. In vivo effect of a new mineral condensed ion (HPA 39) on murine Friend leukaemia. Larnicol N; Augery Y; Le Bousse-Kerdiles C; Degiorgis V; Chermann JC; Teze A; Jasmin C J Gen Virol; 1981 Jul; 55(Pt 1):17-23. PubMed ID: 7299368 [TBL] [Abstract][Full Text] [Related]
7. Therapy of rabies encephalitis. Jackson AC Biomedica; 2009 Jun; 29(2):169-76. PubMed ID: 20128341 [No Abstract] [Full Text] [Related]
8. The antiviral compound HPA-23 can prevent scrapie when administered at the time of infection. Kimberlin RH; Walker CA Arch Virol; 1983; 78(1-2):9-18. PubMed ID: 6686005 [TBL] [Abstract][Full Text] [Related]
9. Survival after treatment of rabies with induction of coma. Willoughby RE; Tieves KS; Hoffman GM; Ghanayem NS; Amlie-Lefond CM; Schwabe MJ; Chusid MJ; Rupprecht CE N Engl J Med; 2005 Jun; 352(24):2508-14. PubMed ID: 15958806 [TBL] [Abstract][Full Text] [Related]
10. [The antiviral activity of the peptide immunomodulator "Gepon" in experimental models of street rabies virus]. Gribencha SV; Kholms RD; Ataullakhanov RI; Barinskiĭ IF Vopr Virusol; 2003; 48(4):40-4. PubMed ID: 12945207 [TBL] [Abstract][Full Text] [Related]
11. Intradermal DNA vaccination in ear pinnae is an efficient route to protect cats against rabies virus. Tesoro-Cruz E; Calderón-Rodríguez R; Hernández-González R; Blanco-Favéla F; Aguilar-Setién A Vet Res; 2008; 39(2):16. PubMed ID: 18215393 [TBL] [Abstract][Full Text] [Related]
12. Progress in the development of antiviral therapy for HTLV-III-associated diseases. Yarchoan R; Broder S Important Adv Oncol; 1987; ():293-311. PubMed ID: 2841232 [No Abstract] [Full Text] [Related]
13. [An application of desoxyribonuclease in experimental rabies]. Dediuk EA Mikrobiol Zh; 1967; 29(4):308-11. PubMed ID: 5619953 [No Abstract] [Full Text] [Related]
14. [Experiences with oral immunization of foxes against rabies in Hesse]. Wachendörfer G; Frost JW; Gutmann B; Hofmann J; Schneider LG; Eskens U; Dingeldein W Tierarztl Prax; 1986; 14(2):185-96. PubMed ID: 3738893 [TBL] [Abstract][Full Text] [Related]
15. Immunogenicity of the ERA G 333 rabies virus strain in foxes and raccoon dogs. Bankovskiy D; Safonov G; Kurilchuk Y Dev Biol (Basel); 2008; 131():461-6. PubMed ID: 18634508 [TBL] [Abstract][Full Text] [Related]
16. Inhibition of rabies virus in vitro by the ammonium-5-tungsto-2-antimoniate. Tsiang H; Atanasiu P; Chermann JC; Jasmin C J Gen Virol; 1978 Sep; 40(3):665-8. PubMed ID: 690613 [TBL] [Abstract][Full Text] [Related]
17. Reverse transcriptase activity (RTA) in lymphocyte cultures of AIDS patients treated with HPA-23. Buimovici-Klein E; Ong KR; Lange M; Englard A; McKinley GF; Reddy M; Grieco MH; Cooper LZ AIDS Res; 1986; 2(4):279-83. PubMed ID: 2434115 [TBL] [Abstract][Full Text] [Related]
18. Experimental rabies in skunks and foxes. Pathogenesis of the spongiform lesions. Charlton KM; Casey GA; Webster WA; Bundza A Lab Invest; 1987 Dec; 57(6):634-45. PubMed ID: 3695410 [TBL] [Abstract][Full Text] [Related]